| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-09 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |